← Open Payments lookup

MAXINE LEWIS: Open Payments

NPI 1649809831 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$596 in 22 payments from 13 companies in 2025. Trend: 2023 $76 · 2024 $229 · 2025 $596

Food & beverage: $596
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation3$85
GlaxoSmithKline, LLC.3$84
Daiichi Sankyo Inc.3$73
AstraZeneca Pharmaceuticals LP2$54
Merck Sharp & Dohme LLC2$54
E.R. Squibb & Sons, L.L.C.2$49
Janssen Biotech, Inc.1$44
PFIZER INC.1$34
Gilead Sciences, Inc.1$31
Regeneron Healthcare Solutions, Inc.1$30

Products named: KISQALI, KEYTRUDA, OJJAARA, Enhertu, RYBREVANT, IBRANCE, Trodelvy, BLENREP.

Industry payments across MD — which companies pay providers there.